High prevalence of peripheral arterial disease in HIV-infected persons

被引:91
作者
Periard, Daniel [1 ]
Cavassini, Matthias [2 ]
Taffe, Patrick [3 ]
Chevalley, Melanie [1 ]
Senn, Laurence [2 ]
Chapuis-Taillard, Caroline [2 ]
De Valliere, Serge [2 ]
Hayoz, Daniel [1 ,4 ]
Tarr, Philip E. [2 ]
机构
[1] Univ Hosp CHUV, Angiol Serv, CH-1011 Lausanne, Switzerland
[2] Univ Hosp CHUV, Infect Dis Serv, CH-1011 Lausanne, Switzerland
[3] Swiss HIV Cohort Study Data Ctr, Lausanne, Switzerland
[4] Hop Cantonal Fribourg, Fribourg, Switzerland
关键词
D O I
10.1086/527564
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Atherosclerosis has been assessed in human immunodeficiency virus (HIV)-infected persons by using various methods. Peripheral arterial disease (PAD) has not been evaluated, however. We studied the cross-sectional prevalence of lower limb PAD in an HIV-infected population. Methods. PAD was assessed using the Edinburgh Claudication Questionnaire and by measuring the systolic ankle-brachial blood pressure index (ABI) at rest and after exercise. Patients with PAD were further evaluated by duplex scan of lower limb arteries. Results. Ninety-two consecutive HIV-infected patients were evaluated (23.9% women; mean age, 49.5 years; 61.9% current smokers). Claudication was reported by 15.2% of the patients. PAD was found in 20.7% of the patients: 9.8% had an abnormal ABI (< 0.90) at rest, and 10.9% had normal ABI at rest but a > 25% decrease after exercise. Of the patients with PAD, 84.2% were investigated with duplex scan, all of whom had atherosclerotic occlusions or stenoses of the iliac or femoral arteries. Age, diabetes, smoking, and low CD4(+) T lymphocyte counts were identified as independent predictors of PAD. Conclusions. The prevalence of symptomatic and asymptomatic PAD is high in the HIV-infected population and is much higher than expected ( prevalence in the general population, similar to 3% at 60 years). This study suggests the presence of an epidemic of PAD similar to 20 years earlier in the HIV-infected than in the general population. Larger epidemiological studies are needed to better define risk factors and to evaluate whether PAD is associated with increased mortality, as it is in the general population.
引用
收藏
页码:761 / 767
页数:7
相关论文
共 40 条
  • [1] Metabolic syndrome - a new world-wide definition. A consensus statement from the international diabetes federation
    Alberti, KGMM
    Zimmet, P
    Shaw, J
    [J]. DIABETIC MEDICINE, 2006, 23 (05) : 469 - 480
  • [2] *ANTIHIV DRUGS STU, 2003, NEW ENGL J MED, V349, P1993
  • [3] Contribution of 20 single nucleotide polymorphisms of 13 genes to dyslipidemia associated with antiretroviral therapy
    Arnedo, Mireia
    Taffe, Patrick
    Sahli, Roland
    Furrer, Hansjakob
    Hirschel, Bernard
    Elzi, Luigia
    Weber, Rainer
    Vernazza, Pietro
    Bernasconi, Enos
    Darioli, Roger
    Bergmann, Sven
    Beckmann, Jacques S.
    Telenti, Amalio
    Tarr, Philip E.
    [J]. PHARMACOGENETICS AND GENOMICS, 2007, 17 (09) : 755 - 764
  • [4] BAKER JD, 1981, SURGERY, V89, P134
  • [5] Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study
    Carr, A
    Samaras, K
    Thorisdottir, A
    Kaufmann, GR
    Chisholm, DJ
    Cooper, DA
    [J]. LANCET, 1999, 353 (9170) : 2093 - 2099
  • [7] Early structural and functional changes of the vasculature in HIV-infected children - Impact of disease and antiretroviral therapy
    Charakida, M
    Donald, AE
    Green, H
    Storry, C
    Clapson, M
    Caslake, M
    Dunn, DT
    Halcox, JP
    Gibb, DM
    Klein, NJ
    Deanfield, JE
    [J]. CIRCULATION, 2005, 112 (01) : 103 - 109
  • [8] Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
    Cleeman, JI
    Grundy, SM
    Becker, D
    Clark, LT
    Cooper, RS
    Denke, MA
    Howard, WJ
    Hunninghake, DB
    Illingworth, DR
    Luepker, RV
    McBride, P
    McKenney, JM
    Pasternak, RC
    Stone, NJ
    Van Horn, L
    Brewer, HB
    Ernst, ND
    Gordon, D
    Levy, D
    Rifkind, B
    Rossouw, JE
    Savage, P
    Haffner, SM
    Orloff, DG
    Proschan, MA
    Schwartz, JS
    Sempos, CT
    Shero, ST
    Murray, EZ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19): : 2486 - 2497
  • [9] THE PREVALENCE OF PERIPHERAL ARTERIAL-DISEASE IN A DEFINED POPULATION
    CRIQUI, MH
    FRONEK, A
    BARRETTCONNOR, E
    KLAUBER, MR
    GABRIEL, S
    GOODMAN, D
    [J]. CIRCULATION, 1985, 71 (03) : 510 - 515
  • [10] MORTALITY OVER A PERIOD OF 10 YEARS IN PATIENTS WITH PERIPHERAL ARTERIAL-DISEASE
    CRIQUI, MH
    LANGER, RD
    FRONEK, A
    FEIGELSON, HS
    KLAUBER, MR
    MCCANN, TJ
    BROWNER, D
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (06) : 381 - 386